Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Anastrozole peptide?

See the DrugPatentWatch profile for Anastrozole

Anastrozole is not a peptide. It is a non-steroidal aromatase inhibitor, a type of medication used primarily to treat hormone receptor-positive breast cancer in postmenopausal women. It works by reducing the amount of estrogen the body makes, which can slow the growth of cancer cells that depend on estrogen to grow [1].

How does anastrozole work?


Anastrozole belongs to a class of drugs called aromatase inhibitors. These drugs block the action of an enzyme called aromatase, which is responsible for converting androgens into estrogens in the body. By inhibiting aromatase, anastrozole significantly lowers estrogen levels, thereby depriving estrogen-sensitive breast cancer cells of the hormones they need to grow and multiply [1].

Why are people searching for "anastrozole peptide"?


The search for "anastrozole peptide" likely stems from a misunderstanding or an attempt to find information about anastrozole in a broader context that might include peptides. Peptides are short chains of amino acids, and while some medications are peptides, anastrozole is a small molecule drug with a different chemical structure [1]. There is no known drug or therapeutic compound referred to as "anastrozole peptide."

What are the common uses of anastrozole?


The primary approved use for anastrozole is as an adjuvant treatment for early, hormone receptor-positive breast cancer in postmenopausal women. It is also used to treat advanced or metastatic breast cancer in this patient population [1].

What are the risks associated with anastrozole?


Anastrozole, like other aromatase inhibitors, can have side effects. Common side effects include hot flashes, joint pain, fatigue, and mood changes. More serious potential risks include loss of bone mineral density (osteoporosis) and an increased risk of fractures, as well as cardiovascular events [1].

What is the regulatory status of anastrozole?


Anastrozole is approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for its indicated uses in breast cancer treatment. It is available under various brand names and as a generic medication [1].

Where can I find patent information on anastrozole?


Information regarding patents for anastrozole and its formulations can be found through resources that track pharmaceutical patents. DrugPatentWatch.com provides a database of drug patents, which may include details on anastrozole's patent status and expiration dates [2].

Sources


1. Anastrozole. National Cancer Institute. https://www.cancer.gov/drug-terms/anastrozole
2. DrugPatentWatch.com. https://drugpatentwatch.com/



Other Questions About Anastrozole :

Anastrozole generic manufacturers?